BMED holdings

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	DHRDanaher Corporation	Equity	5.22%	$703K	3,232	US
2	MRNAModerna, Inc. Common Stock	Equity	5.09%	$685K	3,476	US
3	GILDGilead Sciences Inc	Equity	5.06%	$681K	4,627	US
4	ABBVABBVIE INC.	Equity	4.92%	$662K	2,431	US
5	TMOThermo Fisher Scientific, Inc.	Equity	4.37%	$588K	902	US
6	XTSLABLK CSH FND TREASURY SL AGENCY	Cash	4.16%	$560K	560,000	US
7	JNJJohnson & Johnson	Equity	4.14%	$557K	2,172	US
8	IQVIQVIA Holdings Inc.	Equity	3.70%	$498K	1,923	US
9	WATWaters Corp	Equity	3.67%	$493K	1,150	US
10	BIIBBiogen Inc. Common Stock	Equity	3.49%	$470K	2,150	US
11	MTDMettler-Toledo International	Equity	3.46%	$465K	304	US
12	VRTXVertex Pharmaceuticals Inc	Equity	3.31%	$445K	884	US
13	MRKMerck & Co., Inc.	Equity	3.11%	$419K	2,943	US
14	EWEdwards Lifesciences Corp	Equity	2.97%	$399K	4,736	US
15	ROPRoper Technologies, Inc. Common Stock	Equity	2.69%	$361K	853	CH
16	DXCMDexCom, Inc.	Equity	2.44%	$328K	3,881	US
17	AMGNAmgen Inc	Equity	2.43%	$327K	802	US
18	ILMNIllumina Inc	Equity	2.29%	$308K	1,164	US
19	HALOHalozyme Therapeutics, Inc.	Equity	2.07%	$278K	2,531	US
20	GMABGenmab A/S ADS	Equity	1.94%	$261K	7,231	DK
21	NOVNNOVARTIS AG	Equity	1.84%	$248K	1,754	CH
22	ARGXargenx SE American Depositary Shares	Equity	1.69%	$227K	277	BE
23	CRLCharles River Laboratories International, Inc.	Equity	1.53%	$205K	689	US
24	PFEPfizer Inc.	Equity	1.52%	$205K	7,359	US
25	WUXI BIOLOGICS CAYMAN	Equity	1.49%	$200K	29,000	CN
26	GHGuardant Health, Inc. Common Stock	Equity	1.44%	$193K	1,166	US
27	USDProShares Ultra Semiconductors	Cash	1.39%	$187K	187,307	US
28	NBIXNeurocrine Biosciences Inc	Equity	1.37%	$184K	1,306	US
29	BMYBristol-Myers Squibb Co.	Equity	1.35%	$182K	3,058	US
30	CYTKCytokinetics Inc.	Equity	1.33%	$179K	2,888	US
31	ROIVRoivant Sciences Ltd. Common Shares	Equity	1.32%	$177K	5,171	US
32	GALDGALDERMA GROUP N AG	Equity	1.30%	$175K	896	CH
33	ABTAbbott Laboratories	Equity	1.28%	$172K	1,746	US
34	AAgilent Technologies Inc.	Equity	1.25%	$167K	996	US
35	BMRNBioMarin Pharmaceuticals Inc	Equity	1.03%	$139K	2,533	US
36	TEMTempus AI, Inc. Class A Common Stock	Equity	0.92%	$124K	1,785	US
37	AXSMAxsome Therapeutics, Inc	Equity	0.91%	$123K	721	US
38	PTGXProtagonist Therapeutics, Inc	Equity	0.90%	$121K	866	US
39	INCYIncyte Genomics Inc	Equity	0.73%	$99K	875	US
40	BRKRBruker Corporation	Equity	0.71%	$95K	1,648	US
41	UCBUnited Community Banks, Inc.	Equity	0.62%	$84K	370	BE
42	RVMDRevolution Medicines, Inc. Common Stock	Equity	0.58%	$78K	416	US
43	ALKSAlkermes Inc. plc	Equity	0.57%	$76K	1,902	US
44	PTCTPTC Therapeutics, Inc.	Equity	0.47%	$63K	1,001	US
45	DNTHDianthus Therapeutics, Inc. Common Stock	Equity	0.44%	$60K	723	US
46	MBXMBX Biosciences, Inc. Common Stock	Equity	0.44%	$59K	1,103	US
47	COGTCogent Biosciences, Inc. Common Stock	Equity	0.41%	$55K	1,813	US
48	VRDNViridian Therapeutics, Inc. Common Stock	Equity	0.28%	$37K	2,025	US
49	SGMTSagimet Biosciences Inc. Series A Common Stock	Equity	0.12%	$17K	1,875	US
50	SMMTSummit Therapeutics Inc. Common Stock	Equity	0.09%	$12K	706	US
51	AVTXAvalo Therapeutics, Inc. Common Stock	Equity	0.09%	$12K	867	US
52	EIKNEikon Therapeutics, Inc. Common Stock	Equity	0.08%	$10K	1,392	US
53	ABIOMED CVRS	Equity	0.00%	$371	246	US
54	MRTXMIRATI THERAPEUTICS INC	Equity	0.00%	$261	334	US
55	GBPGBP CASH	Cash	0.00%	$169	127	GB
56	BLUEPRINT MEDICINES CORP	Equity	0.00%	$109	110	US
57	DUMMYVIGIL NEUROSCIENCE INC CVR	Equity	0.00%	$24	484	US
58	HKDAMTD Digital Inc. American Depositary Shares (every five of which represent two Class A Ordinary Shares)	Cash	0.00%	$19	150	HK
59	KRWKRW CASH	Cash	0.00%	$0	9	KR
60	KRRBIOKORRO BIO INC CVR	Equity	0.00%	$0	420	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.